The Compounding Pharmacy of America

Form 483 issued February 21, 2018 · Knoxville, Tennessee

Inspection
Jan 26 – Feb 1, 2018
Observations
2
Pages
1
FEI number
3011504027

In short: On February 21, 2018, FDA issued a Form 483 with 2 observations to The Compounding Pharmacy of America in Knoxville, Tennessee (FEI 3011504027) after an inspection that ran Jan 26 – Feb 1, 2018. The investigator was Brandon C. Heitmeier. Most observations concern production and facilities & equipment; the most-cited regulation is 21 CFR 211.67 (equipment cleaning and maintenance).

At a glance

Production and facilities & equipment account for 2 of 2 observations.

Production1
Facilities & equipment1

Most cited: 21 CFR 211.113 (1×) · 211.67 (1×)

What FDA observed

Preview: the opening words of each observation

Dashed: section inferred by FDA Intel and checked against the regulation text

  1. 01

    Media fills were not performed that closely simulate aseptic production operations incorporating, as appropriate, worst-case activities…

  2. 02

    Hazardous drugs were produced without providing adequate containment, segregation, and/or cleaning of work surfaces, utensils, and/or…

The full 483

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at The Compounding Pharmacy of America?

FDA listed 2 observations on this Form 483, mostly about production and facilities & equipment. The most-cited regulation is 21 CFR 211.67 (equipment cleaning and maintenance). The opening words of each observation are shown on this page.

Who inspected The Compounding Pharmacy of America?

Brandon C. Heitmeier is named on this Form 483, for the inspection of Jan 26 – Feb 1, 2018. Each investigator has a profile showing what they cite most.

When was The Compounding Pharmacy of America inspected by FDA?

The inspection ran Jan 26 – Feb 1, 2018, and the Form 483 is dated February 21, 2018.

How do I get the full Form 483 for The Compounding Pharmacy of America?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free